alpha-glucosidase (CHO) (Genzyme).

Robin H, Lachmann

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 2005

Data sources: Europe PubMed Central

alpha-glucosidase (CHO) (Genzyme).

descriptionPublicationkeyboard_double_arrow_right Article 25 Jan 2005 English Journal:Current opinion in investigational drugs (London, England : 2000), volume 5 (issn: 1472-4472,

Copyright policy )

Authors: Robin H, Lachmann;

pmid: 15535432

alpha-glucosidase (CHO) (Genzyme).

- Summary
- Subjects
- Metrics

Abstract

Genzyme General is developing recombinant human alpha-glucosidase, produced in mammalian cell culture, as a potential treatment for Pompe disease. By July 2004, enrollment was completed in two clinical trials and an observational study in adults. Genzyme was planning to file for regulatory approval in Europe during 2004, followed by filings in the US and Japan in mid-2005.

Related Organizations

University of Cambridge
United Kingdom
Cambridge University Hospitals NHS Foundation Trust
United Kingdom
Addenbrooke's Hospital
United Kingdom

Keywords

Clinical Trials as Topic, Structure-Activity Relationship, Treatment Outcome, Glycogen Storage Disease Type II, Animals, Humans, alpha-Glucosidases, Recombinant Proteins

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average